EUROAPI SA (EAPIF, $2.46) was a top loser over the last three months, falling -1 to $2.46 per share. A.I.dvisor analyzed 213 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending April 16, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend. 267 similar cases when EAPIF's price dropped within three months. In out of those 267 cases, EAPIF's price went down during the following month. Based on these historical data, the odds of a Downtrend continuation for EAPIF are